menu
    • menu

    Company profile for AMO Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AMO Pharma is dedicated to making a positive difference for people affected by serious and debilitating diseases, particularly rare or orphan diseases. To do this, we first work to understand the areas of unmet need and the experience of living with any disease we are targeting. We then use our extensive experience in drug development to identify and advance therapies that can significantly improve clinical outcomes while offe...
    AMO Pharma is dedicated to making a positive difference for people affected by serious and debilitating diseases, particularly rare or orphan diseases. To do this, we first work to understand the areas of unmet need and the experience of living with any disease we are targeting. We then use our extensive experience in drug development to identify and advance therapies that can significantly improve clinical outcomes while offering the strongest opportunities for approval. With drugs designed to reduce disease burden, slow disease progression or reduce many or all symptoms of a disease, our goal is to give patients an opportunity for improved

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AMO Pharmaunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Kemp House, 152-160 City Road, London, EC1V 2NX
    Telephone
    Telephone
    +44 (0) 1483 319070
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.amo-pharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/amo-pharma-ltd
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    AMO Pharma Reveals REACHCDM-X Study's Safety Data for AMO-02
    AMO Pharma Reveals REACHCDM-X Study's Safety Data for AMO-02

    15 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amo-pharma-reports-long-term-safety-data-from-reachcdm-x-study-of-amo-02-in-treatment-of-congenital-myotonic-dystrophy-type-1-302555592.html

    PR NEWSWIRE
    15 Sep 2025
    Share Share
    AMO Pharma, PHRI, Venca Research License Deal for ARVC Study
    AMO Pharma, PHRI, Venca Research License Deal for ARVC Study

    08 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amo-pharma-enters-into-license-agreement-with-population-health-research-institute-phri-and-venca-research-inc-to-advance-largest-ever-study-in-treatment-of-arrhythmogenic-right-ventricular-cardiomyopathy-arvc-302548582.html

    PR NEWSWIRE
    08 Sep 2025
    Share Share
    AMO Outlines AMO-02 Myotonic Dystrophy Development Post-FDA Meet
    AMO Outlines AMO-02 Myotonic Dystrophy Development Post-FDA Meet

    02 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amo-pharma-completes-meeting-with-us-fda-and-outlines-plans-to-advance-clinical-development-of-amo-02-tideglusib-in-treatment-of-myotonic-dystrophy-302133891.html

    PR NEWSWIRE
    02 May 2024
    Share Share
    AMO Pharma Announces Collaboration with Population Health Research Institute
    AMO Pharma Announces Collaboration with Population Health Research Institute

    15 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amo-pharma-announces-collaboration-with-population-health-research-institute-to-advance-proof-of-concept-clinical-trial-to-assess-efficacy-of-tideglusib-in-treatment-of-arrhythmogenic-cardiomyopathy-302062622.html

    PR NEWSWIRE
    15 Feb 2024
    Share Share
    AMO Pharma Announces Preclinical Data Showing AMO-02 Improves Muscle Function
    AMO Pharma Announces Preclinical Data Showing AMO-02 Improves Muscle Function

    19 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amo-pharma-announces-preclinical-data-showing-amo-02-improves-muscle-function-glucose-handling-and-cns-function-in-mouse-models-of-duchenne-muscular-dystrophy-301931362.html

    PR NEWSWIRE
    19 Sep 2023
    Share Share
    AMO Pharma Announces Affirming Data from REACH-CDM Clinical Trial for AMO-02
    AMO Pharma Announces Affirming Data from REACH-CDM Clinical Trial for AMO-02

    06 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/amo-pharma-announces-affirming-data-from-reach-cdm-clinical-trial-for-amo-02-in-treatment-of-myotonic-dystrophy-301918241.html

    PR NEWSWIRE
    06 Sep 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search